4.7 Article

Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment

Related references

Note: Only part of the references are listed.
Article Allergy

IL-4 receptor alpha blockade dampens allergic inflammation and upregulates IL-17A expression to promote S aureus clearance in antigen sensitized mouse skin

Juan -Manuel Leyva-Castillo et al.

Summary: IL-4Ra blockade reduces allergic skin inflammation and promotes the clearance of S aureus strain SF8300 from sites of allergic skin inflammation by enhancing IL-17A expression.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Article Dermatology

Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data

Amy S. Paller et al.

Summary: The study findings indicate that dupilumab treatment in children and adolescents with AD does not increase overall infection risk and is associated with lower rates of skin infections compared to placebo.

PEDIATRIC DERMATOLOGY (2022)

Article Dermatology

T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17-Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune Diseases

Charlie Bridgewood et al.

Summary: The use of Dupilumab is associated with seronegative inflammatory arthritis and psoriasis, but not with classic polygenic humoral autoimmune diseases. Pathway analysis suggests that Dupilumab may affect certain cytokine pathways and contribute to immune disorders and other pathological processes.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Microbiology

The Ubiquitous Human Skin Commensal Staphylococcus hominis Protects against Opportunistic Pathogens

Morgan M. Severn et al.

Summary: Human skin is home to a variety of commensal bacteria, including Staphylococcus hominis, which plays an important role in preventing Staphylococcus aureus colonization and infection. It produces multiple signaling molecules that inhibit the virulence factor regulation system of S. aureus and other related species. Synthetic versions of these molecules have shown protective effects against S. aureus-associated skin injuries in animal models.
Letter Allergy

Relieving job: Dupilumab in autosomal dominant STAT3 hyper-IgE syndrome

Olga Staudacher et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Article Allergy

Dupilumab Demonstrates Rapid Onset of Response Across Three Type 2 Inflammatory Diseases

G. Walter Canonica et al.

Summary: This post hoc analysis evaluated the efficacy of dupilumab in patients with moderate to severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. The study found that dupilumab rapidly improved symptoms and maintained effectiveness throughout the treatment period.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Article Cell Biology

Conditions That Simulate the Environment of Atopic Dermatitis Enhance Susceptibility of Human Keratinocytes to Vaccinia Virus

Matthew G. Brewer et al.

Summary: Individuals with atopic dermatitis (AD) are more susceptible to viral infections, but little is known about how the inflammatory environment affects the susceptibility of skin cells to viruses. This study found that under conditions simulating AD, keratinocytes become more susceptible to vaccinia virus (the causative agent of eczema vaccinatum), and this susceptibility can be reduced by inhibiting JAK.

CELLS (2022)

Article Allergy

Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis

Evgeny Berdyshev et al.

Summary: Inhibition of IL-4/IL-13 signaling by dupilumab allows restoration of skin lipid composition and barrier function in patients with moderate-to-severe AD. Treatment with dupilumab significantly decreased TEWL in AD lesions, normalized lipid composition, and increased ceramide chain length in lesional and non-lesional stratum corneum of AD patients, achieving a full response after 8 weeks of treatment.

ALLERGY (2022)

Review Allergy

The infectious complications of atopic dermatitis

Vivian Wang et al.

Summary: Atopic dermatitis is a chronic inflammatory skin disease that increases the risk of skin and systemic infections. Preventive therapy focuses on improving skin barrier and anti-inflammatory treatments, with controversy surrounding the use of antibiotics during exacerbation. Further studies are needed to determine the role of antibiotics in treating AD exacerbation.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2021)

Article Allergy

Atopic dermatitis displays stable and dynamic skin transcriptome signatures

Lena Mobus et al.

Summary: Skin transcriptome studies in atopic dermatitis have shown core features of disturbed epidermal differentiation and IL-31/IL-1 signaling activation, along with type 2 inflammation, T(H)17 signaling, and natural killer cell function. IL4RA is a key dysregulated gene, and cyclosporine and dupilumab have distinct effects on the transcriptome in AD patients.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Cell Biology

Neutrophil calprotectin identifies severe pulmonary disease in COVID-19

Hui Shi et al.

Summary: Elevated levels of calprotectin in COVID-19 patients are closely related to disease severity and respiratory status, serving as a potential predictor for patients requiring mechanical ventilation.

JOURNAL OF LEUKOCYTE BIOLOGY (2021)

Article Dermatology

Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children

Jennifer J. Parker et al.

Summary: Six children between the ages of 4 and 18 with severe atopic dermatitis developed new-onset psoriasiform dermatitis after starting dupilumab treatment, with most experiencing clearance or near clearance with the use of topical corticosteroids. One additional patient had pre-existing psoriasis that was unmasked by dupilumab treatment failure. This suggests that effective treatment with dupilumab for atopic dermatitis may lead to the appearance of psoriasiform lesions by affecting the IL-23/T(H)17 pathway.

PEDIATRIC DERMATOLOGY (2021)

Article Biochemistry & Molecular Biology

Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial

Teruaki Nakatsuji et al.

Summary: The study found that the commensal bacterium ShA9 isolated from healthy human skin has the ability to kill Staphylococcus aureus and inhibit inflammation. Local application of ShA9 in patients with atopic dermatitis can reduce adverse events associated with AD.

NATURE MEDICINE (2021)

Article Microbiology

The Kinocidin Interleukin-26 Shows Immediate Antimicrobial Effects Even to Multi-resistant Isolates

Bjoern-Thore Hansen et al.

Summary: Interleukin 26 shows strong bactericidal activities against various bacterial species, particularly effective against Gram-positive bacteria.

FRONTIERS IN MICROBIOLOGY (2021)

Article Microbiology

Staphylococcal TSST-1 Association with Eczema Herpeticum in Humans

Patrick M. Schlievert et al.

Summary: Patients with atopic dermatitis, especially those with eczema herpeticum, are more likely to be infected with Staphylococcus aureus and produce toxic shock syndrome toxin-1. The presence of these superantigens, along with herpes simplex virus reactivation, can potentially harm the skin barrier and exacerbate symptoms.

MSPHERE (2021)

Article Microbiology

Changes in Skin and Nasal Microbiome and Staphylococcal Species Following Treatment of Atopic Dermatitis with Dupilumab

Caroline Meyer Olesen et al.

Summary: The study found that treatment with dupilumab led to significant changes in the skin microbiome of AD patients, with a decrease in Staphylococcus aureus and an increase in Staphylococcus epidermidis and Staphylococcus hominis. Clinical symptoms improved significantly, suggesting a beneficial role of commensal staphylococci in AD.

MICROORGANISMS (2021)

Article Allergy

Dupilumab Therapy Improves Stratum Corneum Hydration and Skin Dysbiosis in Patients With Atopic Dermatitis

Seung-Ju Lee et al.

Summary: This study found that treatment with dupilumab can increase the stratum corneum hydration levels in both lesional and non-lesional skin of atopic dermatitis patients, correlating with improvements in disease severity. Additionally, dupilumab reduced the abundance of Staphylococcus aureus while increasing the abundance of Cutibacterium and Corynebacterium species, which were associated with an increase in stratum corneum hydration levels.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2021)

Article Biochemistry & Molecular Biology

KEGG: integrating viruses and cellular organisms

Minoru Kanehisa et al.

Summary: KEGG is a curated resource integrating eighteen databases categorized into systems, genomic, chemical and health information, providing mapping tools for understanding cellular and organism-level functions from genome sequences and other molecular datasets. The network variation maps in the KEGG database show how different pathogens and environmental factors influence cellular signaling pathways.

NUCLEIC ACIDS RESEARCH (2021)

Review Biochemistry & Molecular Biology

Interleukin-17A and Keratinocytes in Psoriasis

Masutaka Furue et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Rheumatology

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

Matthias Jarlborg et al.

ARTHRITIS RESEARCH & THERAPY (2020)

Article Allergy

Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis

Emma Guttman-Yassky et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Article Allergy

IL-4 receptor engagement in human neutrophils impairs their migration and extracellular trap formation

Daniela Impellizzieri et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Article Dermatology

Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis

Lawrence F. Eichenfield et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2019)

Review Biochemistry & Molecular Biology

Toward understanding the origin and evolution of cellular organisms

Minoru Kanehisa

PROTEIN SCIENCE (2019)

Review Allergy

Interactions Between Atopic Dermatitis and Staphylococcus aureus Infection: Clinical Implications

Jihyun Kim et al.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2019)

Review Immunology

Regulation of neutrophils in type 2 immune responses

Lukas E. M. Heeb et al.

CURRENT OPINION IN IMMUNOLOGY (2018)

Article Dermatology

Patients with Atopic Dermatitis Colonized with Staphylococcus aureus Have a Distinct Phenotype and Endotype

Eric L. Simpson et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)

Article Multidisciplinary Sciences

Biphasic influence of Staphylococcus aureus on human epidermal tight junctions

Katja Baesler et al.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)

Article Allergy

Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum

Lianghua Bin et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Article Medicine, General & Internal

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

Lisa A. Beck et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Review Microbiology

Staphylococcal and Streptococcal Superantigen Exotoxins

Adam R. Spaulding et al.

CLINICAL MICROBIOLOGY REVIEWS (2013)

Review Biochemistry & Molecular Biology

Cytokines and the Skin Barrier

Kai H. Haenel et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

Article Cardiac & Cardiovascular Systems

Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm

Priscila Ramos-Mozo et al.

ATHEROSCLEROSIS (2012)

Article Dermatology

Serum lipocalin-2 levels are increased in patients with psoriasis

M. Kamata et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2012)

Article Allergy

Staphylococcus aureus α-toxin modulates skin host response to viral infection

Lianghua Bin et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

Article Allergy

Staphylococcal alpha-Toxin Induces a Higher T Cell Proliferation and Interleukin-31 in Atopic Dermatitis

Margarete Niebuhr et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2011)

Article Allergy

Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response

Donald Y. M. Leung et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Article Allergy

Staphylococcal exotoxins are strong inducers of IL-22: A potential role in atopic dermatitis

Margarete Niebuhr et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)

Review Allergy

Recent insights into atopic dermatitis and implications for management of infectious complications

Mark Boguniewicz et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)

Article Medicine, Research & Experimental

IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice

John S. Cho et al.

JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Dermatology

Role of bacterial superantigens in atopic dermatitis: Implications for future therapeutic strategies

Ivan D. Cardona et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2006)

Article Dermatology

Staphylococcus aureus clonal dynamics and virulence factors in children with atopic dermatitis

H Lomholt et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)

Article Cell Biology

Many chemokines including CCL20/MIP-3α display antimicrobial activity

D Yang et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2003)

Article Medicine, General & Internal

Endogenous antimicrobial peptides and skin infections in atopic dermatitis

PY Ong et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Dermatology

The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading

RM Emerson et al.

BRITISH JOURNAL OF DERMATOLOGY (2000)

Article Biochemistry & Molecular Biology

KEGG: Kyoto Encyclopedia of Genes and Genomes

M Kanehisa et al.

NUCLEIC ACIDS RESEARCH (2000)